ReviewJournal of assisted reproduction and genetics2026
Regulating the future of procreation: a proposed comprehensive framework for in vitro gametogenesis (IVG) in Israel.
Review in Journal of assisted reproduction and genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In vitro gametogenesis (IVG) is a novel reproductive technology that promises to derive functional human gametes from both embryonic and reprogrammed somatic cells. Currently, this technology is still in the experimental stages, but is approaching clinical viability, which necessitates the development of robust regulatory frameworks for its application in human reproduction. As assisted reproductive technologies (ART) are widely utilized in Israel and heavily subsidized by the state, it would be timely to propose a comprehensive framework for incorporating IVG within the nation's fertility treatment landscape. This requires careful integration of Israeli civil law with the administrative regulations established by the nation's Ministry of Health, while carefully navigating the profound cultural and religious sensitivities of the country's major populations, specifically the Jewish and Sunni Muslim communities. Here, we evaluate the application of IVG across a spectrum of reproductive scenarios: overcoming primary and age-related female infertility, facilitating transgender and intersex parenthood, enabling posthumous reproduction, the mass production of donor gametes, same-sex, solo-, and multiplex-parenthood, as well as the prevention of genetic diseases and the controversial prospect of genetic enhancement. Rooted in Israel's strong pro-natalist ethos, the proposed framework suggests that therapeutic applications of IVG aligning with traditional family structures and the imperative to heal will be integrated into the existing public health infrastructure. A nuanced, centralized oversight mechanism that balances the right to parenthood with ethical boundaries is thus proposed, ensuring that the clinical translation of IVG respects both the diverse moral and religious landscapes of Israeli society and the fundamental rights of the child.
Indexed as
Identifiers
42771115What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.